Portugal, July 17 -- Portugal based KEDRION BIOPHARMA GMBH-SUCURSAL PORTUGAL has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Medicines Derived From The Human Plasma, Under Aq 2023_438, For Ulsasi, For The Year 2025. The value of the contract is worth 79200 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....